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ABSTRACT - We added hydrotherapy to 50 patients with spinal muscular atrophy (SMA) who were being 
treated with individual conventional physiotherapy. Hydrotherapy was performed at an approximate temperature 
of 30 degrees Celsius, twice a week, for thirty minutes in children and for forty-five minutes in adults during a 
2-year period. The outcome derived from this combined modality of treatment was rated according to 
physiotherapeutic evaluations, the MMT (Manual Muscular Test), and the Barthel Ladder. Patients were re-
evaluated at 2-month intervals. After two years of ongoing treatment, we were able to observe that the deformities 
in hip, knee and foot were progressive in all SMA Type II patients, and in some Type III. Muscle strength 
stabilized in most SMA Type III patients, and improved in some. MMT was not done in SMA Type II. In all 
patients we were able to detect an improvement in the Barthel Ladder scale. This study suggests that a measurable 
improvement in the quality of daily living may be obtained in patients with SMA Types II and III subjected to 
conventional physiotherapy when associated with hydrotherapy. 
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Spinal muscular atrophy (SMA) manifests as diffuse muscle weakness secondary to 
degeneration of the anterior horn cells and bulbar nuclei without pyramidal tract involvement 5 , 6 , 7 . 
* Fisioterapeuta, Mestre em Neurociências Universidade Federal de São Paulo - Escola Paulista de 
Medicina (UNIFESP-EPM); **Doutor em Neurologia,UNIFESP-EPM; ***Mestranda em Neurociências 
UNIFESP-EPM; ****Livre Docente em Neurologia UNIFESP-EPM. Aceite: 6-março-1996. 
Fisiot. Márcia Cristina Bauer Cunha - Disciplina de Neurologia, Escola Paulista de Medicina, UNIFESP-
Rua Botucatu 762 - 04023-900 São Paulo SP - Brasil. 
Atrofia muscular espinhal tipo II (intermediária) e III (Kugelberg-Welander): evolução de 50 pacientes 
com fisioterapia e hidroterapia em piscina 
RESUMO - A hidroterapia foi realizada em SO pacientes com atrofia muscular espinhal, os quais foram também 
tratados com fisioterapia individual convencional. O tratamento hidroterápico foi realizado em piscina aquecida 
numa temperatura de aproximadamente 30° Celsius, duas vezes por semana, durante 30 minutos em crianças e 
45 minutos em adultos num período de dois anos. Os benefícios deste tipo de tratamento foram avaliados de 
acordo com a evolução clínica, o MMT(Teste de Força Muscular) e a Escala de Barthel. Os pacientes foram 
reavaliados a cada dois meses. Após dois anos de tratamento nós observamos que as deformidades nos quadris, 
joelhos e pés foram progressivas em todos os pacientes do Tipo II e em alguns do Tipo III. Houve estabilização 
da força muscular na maioria dos pacientes com SMA Tipo III, e melhora da força em alguns; nos pacientes com 
SMA Tipo II este teste não pode ser realizado. Em todos os pacientes pudemos verificar melhora em realção à 
Escala de Barthel. Este estudo sugere que houve melhora destes pacientes com SMA Tipos II e III em relação as 
atividades de vida diária quando a fisioterapia convencional foi associada a hidroterapia. 
PALAVRAS-CHAVES: fisioterapia, hidroterapia, atrofia muscular espinhal. 
There are at least 3 types of SMA 1 9 . Those which affect children include SMA I, a serious condition 
(Werdnig-Hoffmann disease), and SMA II (intermediary form). SMA III (Kugelberg-Weiander) is a 
more benign form which becomes evident in late childhood or adolescence 1 1 5 , 2 2 . In spite of this 
heterogeneity all of the different forms are caused by the same genetic error on chromosome 5 
( 5 q ) 3 , l \ It is certain that most, if not all, of the patients with SMA have a progressive motor 
deterioration, in spite of conventional physiotherapic treatment 4. 
The main purpose of this study was to evaluate the potential benefits of hydrotherapy as a 
supplementary rehabilitation method for SMA Types II and III patients. 
METHOD 
We treated 50 patients with SMA Types II (intermediary) amd HI (Kugelberg-Welander). The diagnosis 
was based on clinical presentation, EMG study and muscle biopsy, according to standard criteria. Thirty patients 
were Type II, 17 males (56,6%) and 13 females (43,3%); and 20 were Type III, 11 males (55%) and 9 females 
(45%). For Type II patients, ages varied from 1 year and 10 months to 10 years and 1 month (mean = 2.9 years; 
median = 2,3 years); for Type III patients, ages varied from 6 to 40 years (mean = 18 years; median = 15 years). 
Patients were examined every 2 months always by the same professional (MCBC) who also performed 
some of the hydrotherapy sessions. Parameters included: a) deformities in jo in t s 1 3 - 6 ; b) development of 
scoliosis 2 1- 2 4- 2 5; c) evolution of muscular strength (Manual Muscular Test, MMT) 7 , 2 4 ; d) Barthel Ladder 1 7 ; and e) 
motorial activities 2 0- 2 2. 
Patients were treated for 2 years with individual physiotherapy once a week, and hydrotherapy and 
therapeutic swimming (Halliwick method) 1 0 - 1 2 - 1 3 1 6 - 2 1 , 2 6 in a heated swimming pool at an approximate temperature 
of 30C twice a week. Hydrotherapy lasted 30 minutes for children and 45 minutes for adults. Individual 
physiotherapy consisted of cinesiotherapy with respiratory exercises", and stretching 3. 
RESULTS 
Table 1 shows that the degrees of deformities in the hips, knees and feet increased in all 50 
patients during the 2-year interval of our study. 
Table 2 shows that the degrees of scoliosis in our Type II patients was more pronounced than 
in Type III, and as the disease progressed, in spite of the treatment there was an increase in the 
overall number of patients who developed scoliosis and kyphosis. 
Only Type III patients were analysed with the MMT since that test is not reliably performed in 
small children. Table 3 shows that muscle strength either stabilized or improved in this group of patients. 
Table 4a shows that 9 3 % of Type II and 100% of Type III patients improved their daily 
activities(Barthel Ladder) after 2 years of treatment. Table 4b shows in detail the specific areas of 
improvement. 
Table 5a shows that Type II patients improved their motorial activities except for walking. 
Four patients lost their walking capacity during the treatment. Type III patients improved all motorial 
activities after the treatment including walking (Table 5b). 
DISCUSSION 
1. Physiotherapic aspects 
There are limited data on physiotherapic and hydrotherapic treatment applied to SMA patients. 
In 1986, Bussi and Mangosto mentioned the importance of individual physiotherapy, respiratory 
and "thermohydrotherapy", for SMA patients, applied for 20 minutes in a swimming pool heated at 
30C. The authors did not describe objective results, but mentioned the beneficial psychological 
effects that the water has brought to their patients 4. 
We applied individual physiotherapy and hydrotherapy in 50 patients for 2 years. Since 
gravity has no effect in water, our patients were able not only to float but also to accomplish 
a larger range of movements. Subjectively we think that the psychological effects were also 
remarkable. Patients felt the freedom to move around, the opportunity to unleash themselves 
emot ional ly , and the feeling of success and accompl i shment . These factors led to an 
improvement in their physical condition and well-being. 

2. Deformities 
In our present study we showed, in spite of physiotherapic and hydrotherapic treatment, that 
almost all patients experienced deformities worsening mainly in the hips, knees and feet. Patients 
with SMA Type II were the most affected developing more deformities than Type III. We did not 
notice any deformity in the upper limbs. 
Spinal deformities were also frequent in our patients. Scoliosis and kyphoscoliosis after age 
3 and collapsing kyphosis before that age are the usual patterns, with most deformities appearing by 
age 6 2 1 . Once the spinal deformity appears, progression without prevention is almost certain 6. Several 
authors, including Schwentker and Gibson 2 4 , have emphasized the potencial for loss of walking 
ability and/or head control following operative intervention for these spinal deformities. With our 
physiotherapic and hydrotherapic treatment we think were able to retard the progression of those 
deformities. None of our patients had the need to undergo surgery corrective of scoliosis. 
3. Muscular strength 
We noticed that with the treatment, SMA Type II patients were able to better stabilize their 
posture, and to better perform rolling and sitting, showing a possible muscular strength stabilization. 
Type III patients that were periodically evaluated through the MMT, showed stabilization and even 
a certain improvement. This improvement was observed mainly in the proximal portions of their 
lower limbs. 
4. Barthel Ladder and Motorial Activities 
That scale and those activities were used pre- and post-treatment to evaluate its benefits 
against the patients' routine activities. 
It is probable that the observed improvement in the performance of their activities be a 
consequence of the treatment. Despite their increasing deformities patients were encouraged, since 
they were able to sustain their muscular strenght and hence better perform their routine daily activities. 
CONCLUSIONS 
After a 2-year physiotherapic and hydrotherapic treatment on SMA Types II and III patients, 
we could conclude that: 
1. Deformities in hips, knees and feet were progressive, even after the treatment. We noticed 
that, in SMA Type II patients, the progression of contractures were faster than in SMA Type III patients. 
2. Fifty-two percent of our patients were affected by scoliosis. Twenty-four percent developed 
the disease during the treatment but none of them has undergone surgery. Kyphosis also affected 
52% of the patients but only 10% developed the disease during the treatment period. 
3. Muscular strength stabilization occurred in Type II patients, and even a certain improvement 
was observed in Type III. Such improvement was observed in the proximal portions of the lower limbs. 
4. According to the Barthel Ladder, and the Motorial Activities, 93.3% of SMA Type II 
patients and 100% of Type III patients showed improvement. The items that achieved better results 
were food, dressing, bath, toilet, use of toilet bowl, and bed to chair transfers. 
5. The hydrotherapy we introduced as a form of supplementary treatment, has brought physical 
and psychological benefits to SMA Types II and III patients. 
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